Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer

The Quick Take
Research to be Presented at the 2026 EORTC-NCI-AACR Symposium Links TROP2 Expression to Treatment Response and Explores its Role in Treatment Sensitivity Findings Suggest Low TROP2 Expression is Associated with Primary Resistance to REQORSA and May Help Guide Patient Selection AUSTIN,...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
Newly Elected To Senate, Talarico Plans To Work With Trump On Federally Legalizing Marijuana
After becoming the first Democrat elected to the U.S. Senate from Texas in decades, James Talarico plans to work with President Donald Trump on federally…
Business
Robbins LLP Urges BULL Investors to Contact the Firm for Information About the Webull Corporation Securities Class Action Lawsuit
SAN DIEGO, Nov. 4, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or…
Business
Mach Travel Solutions Limited Records Highest-Ever H1 Revenue in FY27 with Strong PAT
NEW DELHI, Nov. 4, 2026 /PRNewswire/ -- Mach Travel Solutions Limited (BSE: MACHLTD), formerly Mach Conferences & Events Limited, announced its unaudited…
Business
Une étape majeure pour la biométrie des empreintes digitales sans contact : DERMALOG se qualifie pour le prestigieux programme NIST FastCAP
La qualification réussie de DERMALOG au programme NIST FastCAP marque une avancée importante dans la biométrie des empreintes digitales sans contact et permet…
